"Testicular Hormones" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Hormones produced in the testis.
Descriptor ID |
D013735
|
MeSH Number(s) |
D06.472.334.984
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Testicular Hormones".
Below are MeSH descriptors whose meaning is more specific than "Testicular Hormones".
This graph shows the total number of publications written about "Testicular Hormones" by people in this website by year, and whether "Testicular Hormones" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 2 | 0 | 2 |
1997 | 1 | 0 | 1 |
2002 | 2 | 0 | 2 |
2003 | 5 | 0 | 5 |
2004 | 2 | 0 | 2 |
2007 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Testicular Hormones" by people in Profiles.
-
Hale GE, Zhao X, Hughes CL, Burger HG, Robertson DM, Fraser IS. Endocrine features of menstrual cycles in middle and late reproductive age and the menopausal transition classified according to the Staging of Reproductive Aging Workshop (STRAW) staging system. J Clin Endocrinol Metab. 2007 Aug; 92(8):3060-7.
-
Wu X, Arumugam R, Baker SP, Lee MM. Pubertal and adult Leydig cell function in Mullerian inhibiting substance-deficient mice. Endocrinology. 2005 Feb; 146(2):589-95.
-
Wu X, Arumugam R, Baker SP, Lee MM. Pubertal and adult Leydig cell function in Mullerian inhibiting substance-deficient mice. Endocrinology. 2005 Feb; 146(2):589-95.
-
Hoshiya Y, Gupta V, Segev DL, Hoshiya M, Carey JL, Sasur LM, Tran TT, Ha TU, Maheswaran S. Mullerian Inhibiting Substance induces NFkB signaling in breast and prostate cancer cells. Mol Cell Endocrinol. 2003 Dec 15; 211(1-2):43-9.
-
Lee MM, Misra M, Donahoe PK, MacLaughlin DT. MIS/AMH in the assessment of cryptorchidism and intersex conditions. Mol Cell Endocrinol. 2003 Dec 15; 211(1-2):91-8.
-
Salva A, Hardy MP, Wu XF, Sottas CM, MacLaughlin DT, Donahoe PK, Lee MM. M?llerian-inhibiting substance inhibits rat Leydig cell regeneration after ethylene dimethanesulphonate ablation. Biol Reprod. 2004 Mar; 70(3):600-7.
-
Hoshiya Y, Gupta V, Kawakubo H, Brachtel E, Carey JL, Sasur L, Scott A, Donahoe PK, Maheswaran S. Mullerian inhibiting substance promotes interferon gamma-induced gene expression and apoptosis in breast cancer cells. J Biol Chem. 2003 Dec 19; 278(51):51703-12.
-
Misra M, MacLaughlin DT, Donahoe PK, Lee MM. The role of M?llerian inhibiting substance in the evaluation of phenotypic female patients with mild degrees of virilization. J Clin Endocrinol Metab. 2003 Feb; 88(2):787-92.
-
Misra M, MacLaughlin DT, Donahoe PK, Lee MM. Measurement of Mullerian inhibiting substance facilitates management of boys with microphallus and cryptorchidism. J Clin Endocrinol Metab. 2002 Aug; 87(8):3598-602.
-
Segev DL, Hoshiya Y, Hoshiya M, Tran TT, Carey JL, Stephen AE, MacLaughlin DT, Donahoe PK, Maheswaran S. Mullerian-inhibiting substance regulates NF-kappa B signaling in the prostate in vitro and in vivo. Proc Natl Acad Sci U S A. 2002 Jan 08; 99(1):239-44.